Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE).

ABSTRACT:

Introduction

Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) is a phase II clinical trial testing combination of radiation therapy and irreversible electroporation for intermediate risk prostate cancer BACKGROUND: PCa is the most common non-cutaneous cancer in men and the second leading cause of cancer death in men. PCa treatment is associated with long term side effects including urinary, sexual, and bowel dysfunction. Management of PCa is based on risk stratification to prevent its overtreatment and associated treatment-related toxicity. There is increasing interest in novel treatment strategies, such as focal therapy, to minimize treatment associated morbidity. Focal therapy alone has yet to be included in mainstream guidelines, g

SUBMITTER: Diven M 

PROVIDER: S-EPMC11271032 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature